BioMérieux S.A. BioMérieux S.A.

BioMérieux S.A.

BIM

Rangering i aksjer #1801
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
Aksjekurs
$98.71
Markedsverdi
$11.62B
Endring (1 dag)
1.91%
Endring (1 år)
-25.24%
Land
FR
Handel BioMérieux S.A. (BIM)

Kategori

Healthcare
Aksjeprishistorikk for BioMérieux S.A. (BIM)
Høyeste sluttskurs: $98.28 den 2026-10-01

Laveste sluttskurs: $0.47 den 2002-01-01
Aksjeprishistorikk for BioMérieux S.A. fra 2002 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -18.12%
2025 19.87%
2024 -3.27%
2023 5.35%
2022 -25.68%
2021 -2.88%
2020 58.83%
2019 32.64%
2018 -22.37%
2017 80.30%
2016 23.79%
2015 11.80%
2014 2.43%
2013 10.36%
2012 25.01%
2011 -23.88%
2010 -18.81%
2009 50.69%
2008 -29.44%
2007 68.49%
2006 33.52%
2005 27.00%
2004 105,745.40%
2003 -98.59%
2002 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$680.17 19.92%
US
$230.34 5.61%
US
$391.34 108.14%
US
$21.16 49.45%
CN
$172.83 18.48%
US